|
www.umbbiopark.com
For early-stage to mature bioscience companies, the UMB BioPark offers a sophisticated laboratory and office environment on UMB’s vibrant academic medical center campus.
The 10-acre BioPark on the west side of campus will boast 1.2 million square feet of lab and office space in ten buildings plus garage parking and landscaped parks at final build-out. By Fall 2007, 360,000 square feet in two multi tenant buildings and one garage will be completed and initial development plans for a third similar building are underway.
BioPark building designs maximize flexibility to accommodate a range of occupancies from 750-square-foot lab and office suites in a dedicated BioAccelerator to full floor users. Infrastructure meets the requirements of the most demanding science environments while permitting optimum internal planning flexibility with minimum intrusions.
Building One
800 W. Baltimore Street
- Six stories totaling 120,000 square feet
- Opened July 2005
- Fully leased
- Silver level LEED certification
Building Two - Now Leasing
801 W. Baltimore Street
Located at the gateway to the UMB BioPark with southeastern views towards Baltimore’s Inner Harbor, Building Two is a sophisticated, loaded shell lab and office building that will include conference facilities and space suitable for GMP manufacturing. Its flexible design will accommodate a range of occupancies from full floor office and laboratory to smaller users.
Greenfield Sites
Build to Suit Requirements
- Eight additional greenfield sites ranging in size from 80,000 square feet to 120,000 square feet
- Four sites pre-zoned for biomedical research buildings and available immediately for long-term ground sub-lease
- Users may select their own development team
- Sites will be fully integrated into the BioPark and the UMB information technology infrastructure
News
Paragon Bioservices, Inc., a Baltimore-based contract research and manufacturing company, has moved into its new space in the BioPark’s Building Two. Paragon’s expansion into the University of Maryland BioPark more than doubles its previous operating space to 21,000 square feet of state-of-the-art GMP, pre-clinical laboratories and office space. Paragon expects to double its staff by the second quarter of 2009 and expects to employ about seventy people by 2010. Paragon provides research services as well as GMP production of Phase l/11 therapeutic proteins, reagents for diagnostics, and candidate vaccines for pharmaceutical companies, bioscience companies and academic laboratories.
|
|
